Short report: interferon‐α decreases 14C–aminopyrine breath test values in patients with chronic hepatitis C
- 1 June 1994
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 8 (3) , 353-355
- https://doi.org/10.1111/j.1365-2036.1994.tb00301.x
Abstract
SUMMARY: Objective: To investigate the effect of interferon‐α on cytochrome P‐4 50 dependent microsomal function. Methods: The 14C‐aminopyrine breath test was performed before, during and after a standard dose of interferon‐α (3 000000 units three times per week) was administered for at least six months (nine patients with chronic hepatitis C). Results : Mean aminopyrine breath test values obtained during therapy were significantly lower than either pre‐ or post‐treatment, the degree of reduction varying widely between individuals. Pre‐ and post‐treatment aminopyrine breath test values did not differ significantly. Conclusion: Interferon therapy is associated with a significant and transient inhibition of cytochrome P‐450 activity, which should be taken into account when prescribing concurrent therapy with drugs metabolized by this pathway.Keywords
This publication has 11 references indexed in Scilit:
- Interferon-γ inhibits liver regeneration by stimulating major histocompatibility complex class II antigen expression by regenerating liverHepatology, 1993
- Interferon suppresses erythromycin metabolism in rats and human subjectsHepatology, 1993
- Depression of Drug-metabolizing Activity in the Human Liver by Interferon-βHepatology, 1993
- Depression of liver drug metabolism and increase in plasma fibrinogen by interleukin 1 and tumor necrosis factor: A comparison with lymphotoxin and interferonInternational Journal of Immunopharmacology, 1988
- INHIBITION OF THEOPHYLLINE METABOLISM BY INTERFERONThe Lancet, 1987
- Inhibition of antipyrine metabolism by interferon.British Journal of Clinical Pharmacology, 1986
- Depression of cytochrome P-450 and alterations of protein metabolism in mice treated with the interferon inducer polyriboinosinic acid · polyribocytidylic acidArchives of Biochemistry and Biophysics, 1986
- Induction of Xanthine Oxidase and Heme Oxygenase and Depression of Liver Drug Metabolism by Interferon: A Study with Different Recombinant InterferonsJournal of Interferon Research, 1986
- Breath14CO2 after intravenous administration of [14C]aminopyrine in liver diseasesDigestive Diseases and Sciences, 1982